Correlation Engine 2.0
Clear Search sequence regions

  • adduct (1)
  • humans (2)
  • ring size (1)
  • thrombosis (1)
  • warfarin (6)
  • Sizes of these terms reflect their relevance to your search.

    Despite the difficulty in administering a safe dose regimen and reports of emerging resistance, warfarin (1) remains the most widely-used oral anticoagulant for the prevention and treatment of thrombosis in humans globally. Systematic substitution of the warfarin phenyl ring with either 1,3,5,7-cyclooctatetraene (COT) (2), cubane (3), cyclohexane (4) or cyclooctane (5) and subsequent evaluation against the target enzyme, vitamin K epoxide reductase (VKOR), facilitated interrogation of both steric and electronic properties of the phenyl pharmacophore. The tolerance of VKOR to further functional group modification (carboxylate 14, PTAD adduct 15) was also investigated. The results demonstrate the importance of both annulene conferred π-interactions and ring size in the activity of warfarin. Copyright © 2019 Elsevier Ltd. All rights reserved.


    Hui Xing, Sevan D Houston, Xuejie Chen, Da-Yun Jin, G Paul Savage, Jian-Ke Tie, Craig M Williams. Determining the necessity of phenyl ring π-character in warfarin. Bioorganic & medicinal chemistry letters. 2019 Aug 01;29(15):1954-1956

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 31147103

    View Full Text